[go: up one dir, main page]

AU2002257647A1 - Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination - Google Patents

Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination

Info

Publication number
AU2002257647A1
AU2002257647A1 AU2002257647A AU2002257647A AU2002257647A1 AU 2002257647 A1 AU2002257647 A1 AU 2002257647A1 AU 2002257647 A AU2002257647 A AU 2002257647A AU 2002257647 A AU2002257647 A AU 2002257647A AU 2002257647 A1 AU2002257647 A1 AU 2002257647A1
Authority
AU
Australia
Prior art keywords
vaccination
lymphocytes
humans
induction
computer based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002257647A
Inventor
Mathias Eichler-Mertens
Matthias Filter
Peter Walden
Paul Wrede
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CALLISTOGEN AG
Original Assignee
CALLISTOGEN AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CALLISTOGEN AG filed Critical CALLISTOGEN AG
Publication of AU2002257647A1 publication Critical patent/AU2002257647A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002257647A 2001-03-09 2002-03-11 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination Abandoned AU2002257647A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US27425001P 2001-03-09 2001-03-09
US60/274,250 2001-03-09
US29035301P 2001-05-14 2001-05-14
US60/290,353 2001-05-14
US29161001P 2001-05-18 2001-05-18
US60/291,610 2001-05-18
PCT/EP2002/002666 WO2002072627A2 (en) 2001-03-09 2002-03-11 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination

Publications (1)

Publication Number Publication Date
AU2002257647A1 true AU2002257647A1 (en) 2002-09-24

Family

ID=27402639

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002257647A Abandoned AU2002257647A1 (en) 2001-03-09 2002-03-11 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination

Country Status (2)

Country Link
AU (1) AU2002257647A1 (en)
WO (1) WO2002072627A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1618130T3 (en) 2003-04-11 2013-06-24 Survac Aps Therapeutic cancer vaccine
DK1691824T3 (en) * 2003-11-19 2009-07-06 Merck Patent Gmbh Proteins belonging to the BCL-2 family and fragments thereof and their use in cancer patients
GB0408164D0 (en) 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
GB0716992D0 (en) 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
JP4931154B2 (en) 2005-02-28 2012-05-16 オンコセラピー・サイエンス株式会社 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
GB0720118D0 (en) * 2007-10-15 2007-11-28 Achour Adnane Modified mhc class 1 binding peptides
US8455615B2 (en) * 2008-05-01 2013-06-04 Beth Israel Deaconess Medical Center Methods and compositions for prostate cancer immunotherapy
EP2437779B1 (en) * 2009-06-01 2016-10-26 Her Majesty The Queen In Right of Canada as represented by The Minister of Health Reagents and methods for detecting influenza virus proteins
KR20120098992A (en) * 2009-06-23 2012-09-06 이벤투스 디아그노스틱스 이스라엘 리미티드 A method and system for the detection of cancer
US10857219B2 (en) 2014-03-28 2020-12-08 The Board Of Regents Of The University Of Oklahoma Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof
GB201604458D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
TW202039535A (en) * 2018-12-18 2020-11-01 德商英麥提克生物技術股份有限公司 Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2278189A1 (en) * 1997-01-31 1998-08-06 Epimmune, Inc. Peptides and peptide-loaded antigen presenting cells for the activation of ctl
ES2272074T3 (en) * 1998-01-19 2007-04-16 Florian Kern PROCEDURE FOR THE IDENTIFICATION OF PROTEIC FRAGMENTS STIMULATING T-CELLS.

Also Published As

Publication number Publication date
WO2002072627A8 (en) 2005-05-12
WO2002072627A3 (en) 2003-08-07
WO2002072627A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
AU2003256912A1 (en) Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
EP1546206A4 (en) Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes
AU2002257647A1 (en) Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
EP1542711A4 (en) PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR s PROTEINS
EP1337149A4 (en) Vaccine immunotherapy for immune suppressed patients
AU2002361600A1 (en) Soy protein products and methods for producing soy protein
AU2002237195A1 (en) Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
AU2002239151A1 (en) Use of recombinant trypsin for vaccine production
AU2003292405A8 (en) Cancer immunotherapy using polycomb proteins
AU2003203002A1 (en) Polymeric conjugates for delivery of mhc-recognized epitopes via peptide vaccines
AU2003294220A1 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
SG120874A1 (en) Process for the preparation of peptides
AU2003264724A8 (en) Flagellin peptides as adjuvants for vaccines
PL367329A1 (en) Methods for reducing immunogenicity of polypeptides
AU2002312487A1 (en) Nucleoside vaccine adjuvants
AU2003287016A1 (en) Human sarcoma-associated antigens
AU2003302017A1 (en) Cd26-based therapies for cancers and immune disease
IL140888A0 (en) Pharmaceutical compositions comprising peptides for immune neuroprotection
AU2002952524A0 (en) Epstein barr virus peptide epitopes
AU2002342858A1 (en) Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
AU2003232280A1 (en) Peptides for use in antitumor immunotherapy
AU2003261642A1 (en) Recombinant human herpes simplex virus for producing lentivirus vectors
AU2002304681A1 (en) Haemophilus influenzae antigens
AU2002355913A1 (en) Anti-tumor vaccines
GB0228939D0 (en) Peptide presentations for human immunodeficiency disease vaccines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase